Mary Kay Fenton, Chief Financial Officer at ACHILLION PHARMACEUTICALS INC (ACHN), sold 43,500 shares at $10.08 ($438K) on 2015-12-28, disclosed to the SEC on 2015-12-30.
Scheduled sale ($438k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ACHN | SELL | 2015-01-23 | $210K | — | Filing → |
| ACHN | SELL | 2012-01-11 | $168K | — | Filing → |
| ACHN | SELL | 2011-04-06 | $32K | — | Filing → |